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Abstract
Background: Human papillomavirus (HPV) is one of the most common sexually transmitted infections and can be
prevented by vaccination. The purpose of this study is to gain a better understanding, by analysing interview
responses of adolescents and parents, of how adolescent sexual behaviour is approached in families, how
widespread knowledge about HPV is in Andalusia, the autonomous region with the lowest vaccination rate in
Spain, as well as to learn more about the interviewees’ position regarding vaccination.
Methods: A qualitative study by means of 15 focus groups of adolescents (N = 137, aged 14–17 years) and five
focus groups of parents with children of those ages (N = 37) was conducted in the provinces of Granada, Seville
and Jaén (Andalusia, Spain). The audio data were transcribed verbatim, coded and analysed thematically using
NVIVO-10 software.
Results: There were three major results: (1) There is a lack of communication between adolescents and parents
regarding sexual behaviour; (2) In both groups, scarce knowledge about HPV and vaccination was found; (3) Parents
mistrust vaccination due to a lack of qualified and verified information about its benefits.
Conclusions: Healthy adolescent sexual behaviour is aided by communication within the family. Families need
more information based on the evidence about HPV and vaccination. Health professionals are a key element in this
process.
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Background
Adolescence is a key period for the acquisition and con-
solidation of a lifestyle. During this period, both healthy
and harmful habits are established and reinforced [1].
The need for acceptance by others and a low perception
of danger can lead adolescents toward risky health be-
haviours [2].
The prevention of risky behaviour must be approached
from different spheres, among which the family stands
out [3]. For children, parents serve as a model for the
expression of emotions, gender role, sexuality and hu-
man relationships [4]. Strong family bonds can help chil-
dren maintain similar relations of intimacy and affection
with their peers [5]. When sexuality and sexual behav-
iour is not addressed openly in the family, children
might perceive that it is not appropriate to talk about
the subject [4]. Some authors point out that family envi-
ronments with poor communication and/or where the
adolescent does not receive sufficient support, can lead
to a higher probability of the adolescent engaging in
risky sexual behaviour, such as not using a condom and/
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or starting sexual relations at an early age [5]. Due to
the combination of a reluctance in adolescents to talk
about sexuality with their parents, and a possible lack of
knowledge in some parents on how to address this issue
with their children, the collaboration of expert profes-
sionals is often necessary [4]. Adolescence is a stage in
which youngsters face numerous challenges [6], includ-
ing their identity, sexual self-image and sexuality. They
often feel insecure, need the acceptance of the group
and are easily influenced by their peers’ opinions [4].
In Spain, the age for first sexual intercourse in girls
and boys has decreased in recent decades [6, 7]. The
interval in which adolescents are sexually active has been
extended; the age of first sexual intercourse has de-
creased from 17.5 for young adults who are now 22–25
years old to 15.5 for adolescents who are now 16–18 [7].
In addition, a considerable decrease in adolescents’ con-
cerns about sexually transmitted infections (STI) might
lead to an increase of STIs, especially among the youn-
gest [6, 7].
Human papillomavirus (HPV) is one of the most com-
mon STIs. It is estimated that between 80 and 90% of
people who have sexual relations have been or will be in
contact with the virus [8]. The prevalence of HPV infec-
tion in normal cytology worldwide is estimated to be be-
tween 11 and 12%, being the highest for females below
25 years of age [9].
HPV infection can lead to a variety of consequences,
including cervical cancer. In Europe, this type of cancer
is the second most frequent in females aged between 15
and 44 years [9]. It is estimated that 61,072 new cases
arise each year in Europe, leading to around 25,829
deaths per year as a direct consequence. In Spain, 1942
cases of cervical cancer are diagnosed every year, causing
825 deaths per year [10].
Moreover, the infection can lead to other less known
but very important consequences, such as genital warts
and oropharyngeal, penile, anal, vulvar and vaginal can-
cers [10]. Some types of cancer caused by HPV show a
higher prevalence in males than females. Data from the
United States show that the prevalence of high-risk oral
HPV infection in the general population is higher in
males than females (7.3 and 1.4%, respectively) [11].
Currently, evidence shows that the HPV vaccine is
successful in reducing the prevalence of HPV infection
and its consequences [12]. In Spain, three vaccines are
marketed, classified according to the genotypes that they
contain: bivalent (16, 18), quadrivalent (6, 11, 16, 18)
and nonavalent (6, 11, 16, 18, 31, 33, 45, 52, 58) [13].
Since 2007, HPV vaccination has been included in the
Spanish national public health system and is freely avail-
able for females from 12 years of age [14]. The adminis-
tration of HPV vaccines varies between autonomous
communities, with some regions choosing school-based
and others clinic-based administration. In Andalusia,
vaccines are administered in primary health centres [14].
In 2018, the uptake rate in Spain of the first and sec-
ond dose of the HPV vaccine was 84.9 and 72.8% re-
spectively [15]. Considering those figures, Andalusia is
the autonomous community with the lowest HPV vac-
cine uptake rates in Spain: 75.2% for the first dose and
59.9% for the second [15]. Although little data exist on
overall uptake rates in Europe, Spain ranks among the
countries with the highest vaccination rate when com-
pared to other countries with available data [13].
The qualitative approach to HPV vaccination from the
perspective of adolescent girls and their parents has been
studied by different authors, focusing on the reasons that
lead to accepting or refusing the vaccine. These investi-
gations mention as some of the reasons that influence
vaccine refusal, a lack of information from parents about
the risks and consequences of HPV infection, fear of
vaccine safety as well as doubts about its efficacy, and
the belief that daughters were too young to be sexually
active [16–23]. According to these studies, parents were
more motivated to have their children vaccinated when
the recommendation came from an authority, when they
received advice from their health professionals, and
when they had a strong desire to prevent illness in their
daughters [16, 18, 19, 24].
There are few studies that analyse a social discourse
around HPV and vaccination in Spain, especially by ado-
lescents [25]. Our research approaches this topic from
the perspective of its protagonists, emphasising the study
of the specific factors at work in the region of Andalusia,
which has the lowest HPV vaccination uptake rates in
Spain [15].
In view of these circumstances, the aim of this study
was to identify how adolescent sexual behaviour is
approached in families by analysing interview answers
from adolescents and parents, as well as to explore their
knowledge about HPV and learn more about their pos-
ition regarding vaccination.
Methods
A study was carried out using a qualitative methodology
with a content analysis about adolescent sexual behav-
iour, HPV and its vaccine with adolescents and parents
to learn more about the interviewees’ experiences and
opinions. This study involved 20 focus groups (FGs) and
was carried out between February and May 2017 in the
cities of Jaén, Granada and Seville (Andalusia, Spain).
Sample
The participants were students aged between 14 and 17,
and parents with children of those ages. This age group
coincides with the average age range for the first sexual
intercourse [7] and allows for previous HPV vaccination.
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The participants were contacted through their school
because, since education is compulsory at that age range,
adolescents spend most of their time at school.
A purposive sample was used. First, we got in touch
with primary care nurses assigned to the schools who
helped us communicate with the educational institution.
After receiving agreement from the schools, headmasters
and school counsellors reached out to the families and
agreed on a date to conduct the FGs. Prior to the cre-
ation of a FG, informed consent was obtained from par-
ents and adolescents.
Fifteen FGs with students were created, with a total of
137 participants. Student FGs were created in six state-
subsidised schools, two private schools and seven public
schools.
Five parent FGs were created, with 37 participants in
total, in two state-subsidised schools and three public
schools. The inclusion criterion was to have children of
the ages described above.
The profile of the students and parents who partici-
pated is shown in Table 1.
Data collection
In order to obtain the information from each FG, an ad
hoc script was used (supplementary material), maintain-
ing the same categories of the script for both groups and
modifying the wording of the questions to adapt them to
each group.
Before the start of an interview, researchers were in-
troduced to participants and the goals of the study were
clearly explained. All interviews were conducted in a
classroom assigned by the school headmaster, making
sure each interview could take place in a quiet and ac-
cessible environment, with adequate temperature and
light conditions [26].
The average duration for the compilation of informa-
tion was 40min per group. All sessions were recorded
using two separate digital recorders, with participants’
permission, and notes were taken in order to facilitate
transcription.
A specialist paediatric nurse, with background in
the phenomenon under study and qualitative research,
moderated each FG session. A nurse and anthropolo-
gist with training in qualitative research, observed the
session, took notes and recorded audio. The groups
were identified with the letters FG plus the letter ‘A’,
in the case of the adolescents and the letter ‘P’ in the
case of the parents, followed by the number of the
group. In order to maintain their anonymity, each
group member was also given a number according to
their order of participation.
Analysis
A summative content analysis was carried out as pro-
posed by Hsieh and Shannon [27]. This type of analysis
combines the creation of categories through two ap-
proaches, deductive category application and inductive
category formation. Firstly, through the deductive ap-
proach, the main categories were created, derived from
the research question and the theoretical frame of refer-
ence. Subsequently, emergent categories were identified
arising from the detailed and repeated reading of the
transcribed texts.
In order to guarantee rigor of our methodology and to
enhance trustworthiness [28], two researchers independ-
ently coded the transcripts. Finally, the categories, their
definitions and the texts assigned to each of these cat-
egories were triangulated with the other team members.
For codification, the qualitative analysis QSR NVivo 10
software was used.
Table 1 Characteristics of participants in focus groups
Variable N adolescents (137) N parents (37)
Age (mean, SD) 15.12 (±0.75) 47.45 (±3.82)
Sex Female 82 (59.85%) 35 (94.6%)
Male 55 (40.15%) 2 (5.4%)
HPV vaccination Yes 61 (74.4%)
No 16 (19.5%)
Unkown 5 (6.1%)
Education level Elementary 7 (18.9%)
GCSEa 5 (13.5%)
GCEb 3 (8.1%)
Vocational training 11 (29.7%)
University 11 (29.7%)
aGCSE: General Certificate of Secondary Education
bGCE: General Certificate of Education
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Ethics approval
All participants signed a consent form, where they were
informed of the purpose and objectives of the research
and their participation. In the case of students, parents
signed a consent form. They were also informed of their
right to abandon the investigation at any time without
any consequence. The confidentiality of the participants’
data was ensured during the entire investigation process.
Prior to beginning the research, the approval of Granada
Provincial Research Ethics Committee was obtained.
This committee is integrated in the Network of Ethics
Committees of the Andalusian Public Health System.
Results
The approach to adolescent sexual behaviour in the
family
The adolescents express that they do not approach that
topic with their parents because they are ashamed and
when they do, the conversation almost always tends to
revolve around the use of contraceptive methods.
‘Whenever we talk about it, the little that I talk
about it with them, I’m told to do it with protection
and caution and to make sure it’s with someone who
won’t spill the beans’ (FGA2-2)
‘It’s an embarrassing topic for us’ (FGA1-1)
They consider that their parents have different recom-
mendations about sexual behaviour and that these de-
pend on sex. Boys and girls’ parents insisted on the
importance of protection in both, but besides, parents
oriented girls to have sex with a definitive partner. Add-
itionally, they receive more messages aimed at self-
control in sexual behaviour.
‘I’m told to do it once I have my definite boyfriend,
when it’s the right moment’ (FGA11-8)
The adolescent girls relate that sexual practices of boys
and girls are assessed socially in different ways: having
initiated sexual relations is added value for boys and a
dishonour for girls.
‘If we were boys maybe it’d be easier for us, because if
you are and lose your virginity very young, you rock, but
if you’re a girl, you become a streetwalker’ (FGA13-3)
‘If a girl does it at 15 or 16 years old, she gets a bad
reputation’ (FGA15-5)
Regarding risky sexual practices, many express that they
know peers who perform them, such as not using con-
doms or having multiple sexual partners at early ages.
‘I know people who have done it unprotected and
take the pill to avoid pregnancy, she takes the
morning-after pill and being younger than me; I’m
15, so imagine. At 13, 14 … ’ (FGA11-3)
‘After 14 almost everyone (has had sexual relations),
the vast majority’ (FGA12-6)
Opposite to these statements are those of the parents
who participated; they justify not addressing issues of
sexual behaviour with their children because they are
not interested in that topic and they are too young to
engage in sexual relations.
‘Personally, I really don’t understand; first because
they’re young, they don’t have a partner’ (FGP4-2)
‘They’re 14, they’re too young’ (FGP5-7)
‘I think he is more entertained with the computer’
(FGP5-6)
HPV
Regarding their knowledge about HPV, parents and ado-
lescents think that they have scant knowledge and when-
ever they received any kind of information, it has been
related to vaccination.
‘When we were given the vaccine, we were given a
small introduction’ (FGA6-2)
‘For me, it’s a virus I know little about, only when I
had my daughter vaccinated, but I don’t have much
idea’ (FGP2-3)
Focusing on the transmission mode and means of
prevention, different levels of knowledge are dem-
onstrated by parents and adolescents– while the
former state that it is sexually transmitted and con-
sider a condom to be protection from contagion,
adolescents consider that it is transmitted by fluids
passing from the male to the female, even by lack
of hygiene.
‘I’ve been told and I’ve read it’s when they have sex,
it’s transmitted by having sexual relations, so it’s im-
portant that they use a condom’ (FGP1-7)
‘By semen’ (FGA12-3)
‘By blood, kissing, anything’ (FGA9-6)
‘I think it can also be transmitted by lack of hygiene,
by fungus or something’ (FGA9-5)
González-Cano et al. BMC Public Health         (2021) 21:1476 Page 4 of 9
In general, both students and parents consider that
males are not affected by the infection and that if this
was the case, the consequences would be less than for
females.
‘Boys don’t, I think they can only pass it on’
(FGA11-4)
‘They can have it, but not as much as women’
(FGA3-8)
‘It seems that vaccinating women and men is be-
cause we girls suffer more than them, consequences
are for us girls, not as much for boys’ (FGP5-6)
Vaccines
Adolescents do not have an informed opinion about the
use of vaccines, they accept the decision that their par-
ents make in this respect. Coinciding with this, none of
the parents expressed that they talk about this topic with
their children or ask them about it.
‘My father agrees with the vaccine, my mother al-
ways tells me to get the vaccine when they come to
give it’ (FGA14-2)
‘Her father and I are the ones who decide on his vac-
cination, it is not something that is discussed at
home’ (FGP1-1)
In general, parents trust vaccines and admit their utility,
although sometimes they question them due to a lack of
transparency and the existence of lucrative reasons re-
lated to the economic interests of the pharmaceutical
industry.
‘I question vaccines because I believe there’s little
clarity. It’s not that I consider them useless, I see
there are many lucrative things around vaccines and
pharmaceutical companies and sometimes they con-
fuse us on purpose’. ‘It seems to me that if it’s obliga-
tory, it should be in the vaccination schedule and
force the social security to finance it’ (FGP2-5)
HPV vaccine
The adolescents who participated have scant knowledge
about the HPV vaccine and sometimes this knowledge is
contradictory. In their statements, they claim that it pro-
duces cancer or that it is dangerous, based on comments
that they have heard.
‘A friend of mine went to the doctor and asked about
that vaccine and they said it may cause cancer or
whatever, so my mother went with my friend’s
mother, heard that and said I wouldn’t get it’
(FGA15-1)
Similarly, the parents express that they have scant infor-
mation about the convenience of vaccinating their
daughters. When some participants asked professionals
about vaccinating their daughters, it was suggested to do
what they feel convenient at their own risk, giving a feel-
ing of uncertainty regarding whether they are doing the
right thing.
‘I asked too … the nurse asked me if I wanted her to
be vaccinated, or I didn’t want, but she told me it
was there for it, but said “well, I leave it to you”
Right, the responsibility is mine, but tell me if it’s
good give her the vaccine; but if you haven’t said yes
or no, then I don’t know what to do´ (FGP4-1)
‘In my case, no information at all. You went to your
appointment, can I help you?, papillomavirus, age,
jab, immunisation record, stamp and go home’
(FGP1-1)
Another aspect mentioned in the statements was the re-
lation between the vaccine and sexual relations. In both
groups, we found a belief that once they engage in sexual
relations, the vaccine cannot be administered because it
is not efficacious.
‘I’ve been told that you can’t have sexual relations
before getting vaccine because it doesn’t work’
(FGA15-3)
‘One of the things the nurse told my daughter when
she went to get the vaccine was: “now you can’t have
sexual relations”’ (FGP5-3)
When approaching the vaccine, an important aspect is
the effects after vaccination. In the case of adolescent
girls, none had suffered adverse effects although we
found the testimony of two girls who related that a rela-
tive had suffered a reaction after being given the vaccine,
although the relation between both episodes was not
confirmed.
‘My cousin still hasn’t been diagnosed but got lumps
and many things after getting the second dose of the
vaccine as adverse effects; she wasn’t given the third
dose for that reason. But it hasn’t been confirmed
that it’s because of the vaccine’ (FGA11-1)
In the case of the parents, all but one mother related
that their daughters had not suffered any adverse effect.
This mother commented that they still had not been
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able to clearly establish the relation, that it was she who
had established her daughter’s health issues as a conse-
quence of administration of the vaccine.
‘She got it at school. Three days later, she started
with huge otitis. She got antibiotics, later she got
pharyngitis, after that sinusitis, she felt terrible. I
wondered “is it related to the vaccine? No, how can
it be? It’s a coincidence, that’s all” … Since then, she
started not getting her period … Huge headaches …
To sum up, it’s been 5 years now and this summer
she has presented tremors … We don’t know why; I
think it may still be a reaction to the vaccine’
(FGP3-2)
Discussion
In our research, we found that adolescents do not want
to talk about sexual behaviour in their homes and that
when a conversation takes place, it mainly revolves
around contraceptive methods. Regarding HPV, the
knowledge of both groups is scant. Focusing on vaccin-
ation, we find the same situation, a lack of information
in both groups and complaints from parents about the
lack of information clarity provided by health profes-
sionals in this regard.
Sexual education comprises both informal (e.g.
through family) and formal education (e.g. through
schools). The results of our research coincide with other
studies regarding the approach to informal sexual educa-
tion in families, where parents and adolescents talk very
little about sexual behaviour, being for adolescents their
peers the main source of sexual information [29, 30]. Re-
garding formal education, although some adolescents
consider talks in schools as the most useful source of in-
formation on sexuality and sexual behaviour [6], in
Spain, sexuality education is not regulated. Whether it is
taught or not depends on each school and sexuality-
education workshops are usually implemented by exter-
nal organisations [31]. In Andalusia, there is a specific
programme to approach health promotion in schools
called the ‘Forma Jóven’ programme, which is taught by
health professionals, but this strategy is sometimes not
sufficient since the professionals themselves note that
education is started too late and little time is dedicated
to it [32].
We found gender differences which coincide with the
findings of another study, where social double standards
are proven to exist: it is accepted with greater compla-
cency that boys engage in sexual relations in comparison
with girls [33]. Even on some occasions, parents advise
girls to avoid relations to a greater extent than they ad-
vise boys [6]. In our research, adolescents consider that
sexually active girls are more socially frowned upon than
boys. These statements are supported by other studies
where the participants consider that boys are more in-
terested in sex than girls [6] and affirm that sexually ac-
tive females have less worth and that the active and
seductive role corresponds uniquely to males [34].
Students of FGs were between 14 and 17 years old,
which coincides with the beginning of sexual activity ac-
cording to various studies [7, 35], and as also noted by
the participants. This contrast with the statements of
mothers who claim that their children are too young to
engage in sexual relations. This thought may be consid-
ered a barrier when it comes to communication [36]. It
is important to make parents aware of the fact that sexu-
ality is part of their children’s lives and is something
positive which they are going to face. We consider that a
strategy which may help is for parents to participate in
the training about sexuality and sexual behaviour which
is given to adolescents [37].
Interesting similarities and differences between parents
and students emerged regarding the knowledge about
HPV and its vaccine. In the discourse, as similarity of
both groups, we find the general scarce of knowledge
that coinciding with other studies [38]. As the main dif-
ference, while parents know the transmission mode, stu-
dents relate it to fluids [39] or lack of hygiene [40]. Due
to the lack of knowledge about this infection, they may
fill the knowledge gap with what they know about other
STIs. This leads to the fact that in the verbatims of par-
ents and students we find that the risk of infection is
underestimated, especially in men, which coincides with
previous studies [41].
The gender bias found in both groups is striking since
females are more penalised for their sexual practices by
considering that the infection in males has less severe
consequences [38]. This may lead individuals to think
that males are less at risk and can have relations more
freely, with the responsibility for protection falling onto
females. The lack of awareness of the consequences of
the infection in males may be reinforced by the fact that
in the vaccination schedule in Spain, the HPV vaccine is
only included for females. The vaccination of males
against HPV has proven to be an efficacious measure for
a greater reduction in the incidence of the virus [42].
Regarding vaccination, parents are mostly in favour.
This is reflected in the vaccination rates in Spain, which
are around 97% for the primary vaccination and 95% for
the booster [15]. One of the most frequent reasons for
rejection of vaccination is the belief that economic inter-
ests of pharmaceutical industries prevail over the protec-
tion of health [43, 44]. Both groups of participants agree
that the parents have not talked with their daughters
and sons about the vaccines. As Galbraith-Gyan et al.
points out [45], not considering the concerns of adoles-
cents on the subject can be a limitation for them, since
in the future they will be responsible for their health
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care decisions. In the case of the HPV vaccine, in the
verbatims of parents and adolescents, we find similarities
concerning the lack of knowledge. Parents’ doubts re-
garding the HPV vaccine come from a lack of informa-
tion given by healthcare professionals, which leads to
questioning the effectiveness and importance of the vac-
cine [22, 46]. As we have shown in our research, the
knowledge of HPV that the participants have is related
to the vaccine, so those adolescents who had received
the vaccine and their parents had a little more informa-
tion than the rest. If the information about the virus and
its vaccine had reached more adolescents, perhaps the
uptake rates would have been higher in this population,
as pointed out by Camaño-Puig et al. [17]. Some authors
also suggest as a barrier to vaccination that parents think
that their children are not sexually active yet [23]. In our
study we have not found a relationship in the discourses
of parents and adolescents about HPV vaccination and
sexual behaviour, although it is true that one of the
existing myths about the vaccine is the fact that it in-
creases promiscuity, different investigations have shown
that is not true [47, 48]. It is important that professionals
are informed in order to transmit reliable information
based on evidence to parents. On some occasions, the
lack of knowledge of professionals leads them to present
unclear statements concerning the HPV vaccine and to
also have doubts about it [32]. Evidence suggests that
the vaccine is ideal for administration at early ages, but
we found recommendations from scientific societies
which claim that sexually active females may benefit
from its protective effects [49]. In addition to the above,
in Andalusia in particular, the vaccine is administered in
primary health centres instead of schools. This together
whit the lack of knowledge and information about HPV
and its vaccine, could be the reason for the lower rates
of HPV vaccine uptake. A previous study showed in the
regions of Spain that HPV vaccine was administrated in
schools-based programs the HPV vaccine uptake rate
was 14% higher than in the autonomous communities
that administrated it in primary health centres [50]. This
also concurs with previous investigations that showed
that HPV vaccine uptake rate is higher in those coun-
tries with school-based programs [48, 51, 52].
In general, the participants informed of no cases of ad-
verse effects due to the vaccine except for three partici-
pants, two in the group of students and one informed by
a mother who related that a relative had suffered a reac-
tion after being given the vaccine. Several studies col-
lected by the Global Advisory Committee on Vaccine
Safety of the World Health Organization show that there
is no causal relation between the HPV vaccine and the
emergence of illnesses such as Multiple Sclerosis and
other autoimmune illnesses [53]. Other research, pub-
lished recently, shows that vaccine use is not associated
with an increased risk of autoimmune disorders, al-
though this poses the necessity of conducting more
studies in males in order to know the effects of the vac-
cine on them [54]. A revision of studies, which included
57,580 people, claimed that the vaccine had an accept-
able benefit/risk profile [55]. In a revision carried out by
Arbyn et al., the vaccine was proven to be safe, with no
differences between groups which received the vaccine
and those who received a placebo regarding major and
minor systemic adverse effects [56]. However, it is worth
mentioning that among the criticisms of several aspects
that this revision received is the issue of severe adverse
effects [57].
Strengths and limitations
A strength of this study is that both parents and adoles-
cents’ perceptions on sexual behaviour, HPV and vaccin-
ation are included, allowing a comparison of differences
and similarities in the views of both groups. There were
advantages to discussing these topics in a group setting
since participants gave one another mutual support and
individuals could choose when to speak. The inter-
viewers introduced themselves as nurses; this contrib-
uted to a better willingness of the participants to share
their points of view during the interviews and ask ques-
tions at the end of the FGs. In addition, this study in-
cludes both adolescent boys and girls, which has allowed
us to identify sex differences in opinions regarding HPV
infection and its vaccine. Furthermore, the parent dis-
cussion group includes mothers of both boys and girls,
which has enabled us to specifically analyse families of
adolescents of both sexes.
The fact of not being able to count on more opinions
of parents and not having done FGs with them in private
schools could be considered a limitation, since their ar-
guments could have contributed another perspective in
the groups. We also want to highlight the fact that the
convening of the parents’ meeting was made by the
school, which meant that the parents with less time
availability did not attend, so their argument is absent.
In order to maintain anonymity, the relationship be-
tween parents and children was not taken into account;
this limitation prevents a broader analysis of the results.
Our study reflects perceptions in a specific context and
environment, which in our case is the adolescent from
Andalusia that attends school regularly. More research is
needed to elicit views in different environments.
Conclusions
It is necessary for families to approach children’s sexual
behaviour as part of their education, without ignoring it,
without mistrust and with a gender perspective. Families
need more scientific information based on evidence
about the consequences of HPV infection as well as the
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benefits and effects of vaccination. Healthcare profes-
sionals (physicians and nurses) are a key element for
families when making decisions about the HPV vaccine.
The information they provide influences the health care
quality offered and this must contribute to informed de-
cision making.
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